Thomas S. Reger

Neuroscience · Life Sciences

17h-index1.4kcitations33works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(7), Chemical Synthesis and Analysis(6), Ion channel regulation and function(5), Synthetic Organic Chemistry Methods(5), Asymmetric Hydrogenation and Catalysis(4)

Publications33 total

Science of Sealing: Advanced Materials for High-Temperature Applications
2020· 2 cited
Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Bioorganic & Medicinal Chemistry Letters·2014· 28 citedOpen Access
CCDC 760574: Experimental Crystal Structure Determination
The Cambridge Structural Database·2012Open Access
CCDC 760575: Experimental Crystal Structure Determination
The Cambridge Structural Database·2012Open Access
Pyridyl amides as potent inhibitors of T-type calcium channels
Bioorganic & Medicinal Chemistry Letters·2011· 31 citedOpen Access
CCDC 795828: Experimental Crystal Structure Determination
The Cambridge Structural Database·2011Open Access
Short-Acting T-Type Calcium Channel Antagonists Significantly Modify Sleep Architecture in Rodents
ACS Medicinal Chemistry Letters·2010· 20 citedOpen Access
In Vitro Characterization of T-Type Calcium Channel Antagonist TTA-A2 and In Vivo Effects on Arousal in Mice
Journal of Pharmacology and Experimental Therapeutics·2010· 108 cited
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists
Bioorganic & Medicinal Chemistry Letters·2010· 26 cited
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists
ACS Medicinal Chemistry Letters·2010· 38 cited
Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists
Bioorganic & Medicinal Chemistry Letters·2009· 9 citedOpen Access
Positive Allosteric Interaction of Structurally Diverse T-Type Calcium Channel Antagonists
Cell Biochemistry and Biophysics·2009· 74 cited
Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice
Journal of Clinical Investigation·2009· 81 citedOpen Access
Characterization of α4β1 (CD49d/CD29) on equine leukocytes: Potential utility of a potent α4β1 (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction)
Veterinary Immunology and Immunopathology·2009· 3 cited
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia
Bioorganic & Medicinal Chemistry Letters·2005· 3 citedOpen Access
2‐{2‐[3‐(Pyridin‐3‐yloxy)phenyl]‐2H‐tetrazol‐5‐yl}pyridine: A Highly Potent, Orally Active, Metabotropic Glutamate Subtype 5 (mGlu5) Receptor Antagonist.
ChemInform·2005· 3 cited
2-{2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist
Bioorganic & Medicinal Chemistry Letters·2004· 29 citedOpen Access
Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms
Archives of Biochemistry and Biophysics·2004· 111 cited
Parallel suspension polymerization for high-throughput resin synthesis
Bioorganic & Medicinal Chemistry Letters·2002· 6 cited
ChemInform Abstract: Polymer‐Supported Catalysis in Synthetic Organic Chemistry
ChemInform·2001· 1 cited
page 1 of 2Next →

Frequent Co-authors

Richard L. Kraus(10), Victor N. Uebele(10), Scott M. Doran(10), James C. Barrow(10), Susan L. Garson(10), Kim D. Janda(9), Cindy E. Nuss(9), Jeanine Ballard(9), Cuyue Tang(9), John J. Renger(8), George D. Hartman(8), Thomayant Prueksaritanont(8), Kenneth E. Rittle(7), Steven V. Fox(6), Zhi-Qiang Yang(6), Albert Padwa(6), Yuhsin Kuo(6), Yuxing Li(5), Georgia B. McGaughey(5), Yuxing Li(5)